DMDWarrioR.com was not built out of convenience. It was born out of necessity, frustration, and a refusal to accept a system that moves too slowly while lives are at stake. We are families, patients, and advocates from around the world who have seen firsthand what delay, bureaucracy, and inequality cost. And we are done waiting.

Let us be absolutely clear: we are not here to beg. We are here to demand what should already exist—timely, fair, and affordable access to treatment for every individual living with Duchenne Muscular Dystrophy (DMD). If that requires challenging institutions, confronting decision-makers, or disrupting the status quo, then that is exactly what we will continue to do—relentlessly.

We are a fully independent community. We do not receive funding, donations, or support from pharmaceutical companies, industry groups, or any organization that could compromise our voice. This independence is not incidental—it is intentional. It allows us to speak openly, criticize freely, and advocate without conflict of interest. Our only allegiance is to patients and their families.

What started as a platform for information and solidarity has grown into a global movement. Today, DMDWarrioR.com is visited by nearly half a million users—and that number continues to rise every month. This growth is not driven by marketing budgets or institutional backing, but by trust. Families return because they know we tell the truth, publish what others avoid, and refuse to dilute reality.

To raise awareness in a way that accelerates drug development, not just visibility. Awareness without impact is meaningless—we focus on pressure, accountability, and measurable outcomes.

To publish clinical trials transparently and without country-based discrimination. Access to information should not depend on geography. Every patient, regardless of where they live, deserves to know what exists, what is coming, and what is possible.

To apply continuous pressure on regulatory bodies and health authorities to expedite approval processes. Delays are not abstract—they translate into irreversible progression. We will continue to challenge the FDA, EMA, and national health ministries until urgency replaces inertia.

We are not a passive platform. We are an active force.

We will continue to question, to push, to expose, and to demand—until access to treatment is no longer a privilege, but a right.

We are DMD Warriors